EPID‐based in vivo dosimetry using Dosimetry Check™: Overview and clinical experience in a 5‐yr study including breast lung prostate and head and neck cancer patients

摘要

BackgroundIndependent verification of the dose delivered by complex radiotherapy can be performed by electronic portal imaging device (EPID) dosimetry. This paper presents 5‐yr EPID in vivo dosimetry (IVD) data obtained using the Dosimetry Check (DC) software on a large cohort including breast, lung, prostate, and head and neck (H&N) cancer patients.